Drug Trial Radar · NCT01135212
The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension
Last checked: Nov 19, 2026Latest source record: Aug 24, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
290
Actual
Start
Apr 2010
Primary completion
Apr 2011
Study completion May 2011
Sponsor
- Lead sponsor
- Boryung Pharmaceutical Co., LtdIndustry
- Sponsor type
- Industry
- Collaborators
- Kyungpook National University Hospital; Gyeongsang National University Hospital; Keimyung University; Kosin University Gospel Hospital; Daegu Catholic University Medical Center; Dong-A medical center; Pusan National University Yangsan Hospital; Yeungnam University Hospital; Ulsan University Hospital; Inje University; Pusan National University Hospital
- First posted
- Jun 2, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 19 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical study is to evaluate and compare the efficacy and safety of Fimasartan (60mg / 120mg) with Candesartan(8mg) in patients with mild to moderate hypertension.
Conditions
- Hypertension
Interventions
Fimasartan 60mgDrug
Fimasartan 60mg for mild to moderate hypertension. Take a tablet(filled in Doubleblind capsule) every morning.
Fimasartan 120mgDrug
Fimasartan 120mg for mild to moderate hypertension. Take a tablet(filled in Doubleblind capsule) every morning.
Candesartan cilexetilDrug
Candesartan 8mg for mild to moderate hypertension. Take a tablet(filled in Doubleblind capsule) every morning.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sitting Diastolic Blood PressureTime frame: 12weeks from baseline visit
Locations
1 site in 1 country. Site status is shown where the registry gives one.
KyungPook National University Hospital
Daegu, Daegu, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.